BioAmber is a next generation chemicals company. Its proprietary technology platform combines industrial biotechnology, an innovative purification process and chemical catalysis to convert renewable feedstocks into chemicals for use in a wide variety of everyday products including plastics, food additives and personal care products. BioAmber produces bio-succinic acid in what it believes to be one of the world's largest bio-based chemical manufacturing facilities.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/22/12 | $30,000,000 | Series C |
Cliffton Group Mitsui Global Investment Naxos Capital Sofinna Partners | undisclosed |
